Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content or functionality of the page.
    Difference
    0.1%
    Check dated 2025-04-30T14:21:57.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed information about a Phase II trial studying the combination of azacitidine and pembrolizumab for myelodysplastic syndrome, while retaining some identifiers and collaborators related to the study.
    Difference
    55%
    Check dated 2025-04-16T10:44:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:11:25.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:25:00.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-24T20:17:33.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now indicates that some NLM-NCBI services and products are experiencing heavy traffic, which may impact their performance and availability. Additionally, the status of a service has been updated to 'Unknown' and a previous status of 'Active, not recruiting' has been removed.
    Difference
    2%
    Check dated 2025-02-10T09:28:37.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.